For the Inventor, By the Inventor

Enter assignee name

Institut National De La Sante Et De La Recherche Medicale

USPTO Granted Patents = 1,743

CIPO Patents = 71

EPO Patents = 630

Trademarks = 1

Forward Citations = 8,567

Loading Chart...

Loading Chart...

3,958 inventors (with patents filed for the assignee):

Jose-Alain Sahel (24 out of 44 patents)

Daniel Olive (23 out of 28 patents)

Camille Locht (20 out of 35 patents)

4. Dominique Cathignol (20 out of 26 patents)

5. Jean-Yves Chapelon (18 out of 31 patents)

6. Armand Bensussan (17 out of 20 patents)

7. Mathieu Pernot (16 out of 27 patents)

8. Samir Hamamah (15 out of 15 patents)

9. Olivier Hermine (14 out of 14 patents)

10. Alfredo Hernandez (14 out of 22 patents)

11. Jean-Charles Schwartz (14 out of 62 patents)

12. Didier Letourneur (13 out of 15 patents)

13. Alain Tedgui (13 out of 14 patents)

14. Eli Hatchwell (12 out of 35 patents)

15. Peggy S Eis (12 out of 34 patents)

Core Competencies:

Chronic Pathologies

Gene Signature

Sickle Cell Disease

Immunomodulatory Peptide

Cancer Relapse Prediction

Blood Biomarkers

Neurodegenerative Decline

Genetic Engineering

Ultrasound Ablation Surgery

Antibody Deficiencies

Pulmonary Aeration

Thrombotic Microangiopathies

1,743 patents: Sort by Forward Citations

1. 12486545 - Diagnostic and treatment of chronic pathologies such as Lyme disease (2025-12-02),

2. 12480096 - Clinical gene signature-based human cell culture model and uses thereof (2025-11-25),

3. 12472164 - Masitinib for the treatment of sickle cell disease (2025-11-18),

4. 12377066 - Treatment of diseases associated with biliary system destruction (2025-08-05),

5. 12371741 - Method for detecting a mutation in a microsatellite sequence (2025-07-29),

6. 12365709 - Immunomodulatory peptide (2025-07-22),

7. 12345718 - Method for determining the haemoglobin content of an erythroid cell (2025-07-01),

8. 12343376 - Methods for inhibiting diazepam binding protein (2025-07-01),

9. 12331357 - Methods for assessing risk of developing a viral disease using a genetic test (2025-06-17),

10. 12308126 - Device and method for predicting a relapse of a cancer for a patient (2025-05-20),

11. 12295361 - Organ perfusion device (2025-05-13),

12. 12291750 - Predictive and prognostic use of a miRNA for high grade serous ovarian carcinoma therapeutic care (2025-05-06),

13. 12290325 - Automatic determination of an appropriate positioning of a patient-specific instrumentation with a depth camera (2025-05-06),

14. 12287440 - Method for manufacturing a flux detector of a first and a second ionizing radiation (2025-04-29),

15. 12276000 - Methods for predicting the risk of developing pulmonary colonization/infection by (2025-04-14),

Institut National de la Sante et de la Recherche Medicale (INSERM) is the French National Institute of Health and Medical Research. It is a public scientific and technological institute which focuses on addressing major health challenges, conducting biomedical research, and promoting scientific discoveries. INSERM strives to improve the prevention, diagnosis, and treatment of diseases through cutting-edge medical innovation and fostering collaborations within the international scientific community.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

1,743 Patents

#9 in Paris

#17 in France

#564 in the World

Institut National De La Sante Et De La Recherche Medicale

Forward Citations = 8,567

3,958 inventors:

Jose-Alain Sahel (24 out of 44 patents)

Daniel Olive (23 out of 28 patents)

Camille Locht (20 out of 35 patents)

4. Dominique Cathignol (20 out of 26 patents)

5. Jean-Yves Chapelon (18 out of 31 patents)

Please report any incorrect information to support@idiyas.com

Loading…